Health Catalyst (HCAT) Depreciation & Amortization (CF) (2018 - 2026)

Health Catalyst's Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $12.1 million for Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 1.66% year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.3 million (up 16.35% YoY) and the FY2025 annual result came in at $50.5 million, up 21.89% from the prior year.
• Depreciation & Amortization (CF) was $12.1 million for Q1 2026 at Health Catalyst, down from $12.9 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $12.9 million in Q4 2025 and bottomed at $10.0 million in Q3 2024.
• A 5-year average of $11.4 million and a median of $11.6 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 54.96% — and 2023, when it retreated 17.64%.
• Health Catalyst's Depreciation & Amortization (CF) stood at $11.7 million in 2022, then declined by 11.66% to $10.3 million in 2023, then declined by 0.37% to $10.3 million in 2024, then grew by 25.48% to $12.9 million in 2025, then retreated by 5.95% to $12.1 million in 2026.
• Business Quant data shows HCAT's Depreciation & Amortization (CF) at $12.1 million in Q1 2026, $12.9 million in Q4 2025, and $12.6 million in Q3 2025.